HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

Invacare Files for Chapter 11 Bankruptcy

February 2, 2023 by David Kopf

HME manufacturer Invacare Corp. and two of its U.S. subsidiaries have entered voluntary Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas.

The two U.S. subsidiaries involved in the Chapter 11 filings are Adaptive Switch Laboratories (ASL) and Freedom Designs, according to a report from HMEB sister magazine Mobility Management. A statement from Invacare said its other businesses throughout the rest of the world are not included in these filings.

The Chapter 11 filings are related to a Restructuring Support Agreement (RSA) Invacare entered with substantially all of its debt holders. The RSA reduces the company’s debt balance by approximately $240 million while it provides a new money investment of roughly $60 million of equity capital to repay certain debt obligations and facilitate Invacare’s transformation plan.

“Having the full support of our secured term loan lender and a majority of our convertible noteholders will enable the prearranged filings to proceed efficiently,” said Geoff Purtill, president and CEO of Invacare. “The company expects to emerge with significantly less debt on its balance sheet and will secure additional liquidity to support long-term growth.”

“Invacare has the right leadership, vision and the financial commitment from the sponsorship group to succeed, and we are confident that this Chapter 11 process will result in a comprehensive recapitalization transaction that will not only stabilize liquidity but also de-lever the balance sheet and better position Invacare for future growth,” said Steven Rosen, CEO of Azurite Management, the largest shareholder of Invacare.

Related Articles Read More >

Temporary Restraining Order Reinstates BOC as Accrediting Organization
The reinstatement is effective Jan. 9, 2025.
Fisher & Paykel’s F&P Nova Nasal Mask Now Available in US
The new mask is designed to support easy fitting and sound sleep for sleep apnea patients.
‘Common Sense’ Home Infusion Reform Discussed at Congressional Subcommittee Hearing
NHIA CEO Connie Sullivan urged House members to support the Preserving Patient Access to Home Infusion Act.
AAHomecare CEO to Congressional Subcommittee: ‘We Believe 37% of the Industry Has Gone Out of Business’
Tom Ryan testified about three durable medical equipment bills on Jan. 8.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe